BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25225034)

  • 1. Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.
    Blanke KL; Sacco JC; Millikan RC; Olshan AF; Luo J; Trepanier LA
    Cancer Causes Control; 2014 Nov; 25(11):1513-21. PubMed ID: 25225034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.
    Rhoads K; Sacco JC; Drescher N; Wong A; Trepanier LA
    Toxicol Sci; 2011 Jun; 121(2):245-56. PubMed ID: 21447608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.
    Sacco JC; Abouraya M; Motsinger-Reif A; Yale SH; McCarty CA; Trepanier LA
    Pharmacogenet Genomics; 2012 Oct; 22(10):733-40. PubMed ID: 22850190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity.
    Funk-Keenan J; Sacco J; Wong YY; Rasmussen S; Motsinger-Reif A; Trepanier LA
    J Vet Intern Med; 2012; 26(5):1126-33. PubMed ID: 22816446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women.
    Li Y; Millikan RC; Bell DA; Cui L; Tse CK; Newman B; Conway K
    Breast Cancer Res; 2004; 6(4):R460-73. PubMed ID: 15217514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
    Sacco JC; Trepanier LA
    Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mutations in porcine CYB5A and CYP17A1 on the metabolism of pregnenolone.
    Squires EJ; Gray MA; Lou Y
    J Steroid Biochem Mol Biol; 2019 Dec; 195():105469. PubMed ID: 31509771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study.
    Parada H; Sun X; Tse CK; Olshan AF; Troester MA; Conway K
    Cancer Causes Control; 2017 Sep; 28(9):929-938. PubMed ID: 28695396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study.
    Mechanic LE; Millikan RC; Player J; de Cotret AR; Winkel S; Worley K; Heard K; Heard K; Tse CK; Keku T
    Carcinogenesis; 2006 Jul; 27(7):1377-85. PubMed ID: 16399771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in CYB5R3 is associated with methemoglobin levels in preterm infants receiving nitric oxide therapy.
    Fuller TD; Spracklen CN; Ryckman KK; Knake LA; Busch TD; Momany AM; Murray JC; Dagle JM
    Pediatr Res; 2015 Mar; 77(3):472-6. PubMed ID: 25521918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the individual cytochrome b5 and cytochrome b5 reductase domains of Ncb5or reveals a unique heme pocket and a possible role of the CS domain.
    Deng B; Parthasarathy S; Wang W; Gibney BR; Battaile KP; Lovell S; Benson DR; Zhu H
    J Biol Chem; 2010 Sep; 285(39):30181-91. PubMed ID: 20630863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADH-Cytochrome b5 Reductase 3 Promotes Colonization and Metastasis Formation and Is a Prognostic Marker of Disease-Free and Overall Survival in Estrogen Receptor-Negative Breast Cancer.
    Lund RR; Leth-Larsen R; Caterino TD; Terp MG; Nissen J; Lænkholm AV; Jensen ON; Ditzel HJ
    Mol Cell Proteomics; 2015 Nov; 14(11):2988-99. PubMed ID: 26351264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women.
    Stark K; Straub RH; Rovenský J; Blažičková S; Eiselt G; Schmidt M
    Arthritis Res Ther; 2015 Mar; 17(1):56. PubMed ID: 25890314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential differences in breast cancer risk factors based on CYP1A1 MspI and African-American-specific genotypes.
    Zhu K; Hunter S; Payne-Wilks K; Sutcliffe C; Bentley C; Roland CL; Williams SM
    Ethn Dis; 2006; 16(1):207-15. PubMed ID: 16599372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol intake and invasive breast cancer risk by molecular subtype and race in the Carolina Breast Cancer Study.
    Williams LA; Olshan AF; Tse CK; Bell ME; Troester MA
    Cancer Causes Control; 2016 Feb; 27(2):259-69. PubMed ID: 26705260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk.
    Shore RE; Zeleniuch-Jacquotte A; Currie D; Mohrenweiser H; Afanasyeva Y; Koenig KL; Arslan AA; Toniolo P; Wirgin I
    Int J Cancer; 2008 May; 122(9):2101-5. PubMed ID: 18196582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active cigarette smoking, variants in carcinogen metabolism genes and breast cancer risk among pre- and postmenopausal women in Ontario, Canada.
    Cotterchio M; Mirea L; Ozcelik H; Kreiger N
    Breast J; 2014; 20(5):468-80. PubMed ID: 25052559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.
    Trabert B; Malone KE; Daling JR; Doody DR; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Humphrey MC; Ostrander EA
    Breast Cancer Res; 2007; 9(6):R84. PubMed ID: 18067661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N; Hankinson SE; Colditz GA; Spiegelman D; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Feb; 58(4):667-71. PubMed ID: 9485019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review.
    Keshava C; McCanlies EC; Weston A
    Am J Epidemiol; 2004 Nov; 160(9):825-41. PubMed ID: 15496535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.